Showing results (311-320 of 333) with videos related to

Sort By:
Pageof 34
Digestive Diseases and Sciences|June 1, 1991
Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. I. Clinical aspectsH Tsubouchi, S Hirono, E Gohda, et al.
Carcinogenesis|May 1, 1996
Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley ratsL M Sargent, Y P Dragan, C Sattler, et al.
BMC Bioinformatics|July 20, 2005
Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profilingH Fang, W Tong, R Perkins, et al.
The American Journal of Pathology|August 1, 1994
Transgenic hepatocarcinogenesis in the ratJ R Hully, Y Su, J K Lohse, et al.
Pharmacological Research Communications|July 1, 1987
Effect of histamine H2-receptor antagonists on DNA synthesis in adult rat hepatocytes in primary culture. Cimetidine enhanced hepatocytes proliferation stimulated with insulin and epidermal growth factorS Hirono, E Gohda, H Tsubouchi, et al.
Biochimica Et Biophysica Acta|June 12, 1990
Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failureE Gohda, T Yamasaki, H Tsubouchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566C Erlichman, A A Adjei, S R Alberts, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1997
Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancerJ A Martenson, R Swaminathan, P A Burch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorinR M Goldberg, S H Kaufmann, P Atherton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumorsA A Adjei, C Erlichman, J A Sloan, et al.
Pageof 34